Medicare Enrolled
Monique Brumsey, AGACNP
Acute Care Nurse Practitioner · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Brumsey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Brumsey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Brumsey
Monique Brumsey is an acute care nurse practitioner in Dallas, TX, with 6 years of NPI registration. Based on federal Medicare data, Brumsey performed 1,559 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Brumsey received a total of $4,499 from 40 pharmaceutical and/or device companies across 207 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Brumsey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 6 years of NPI registration
▲ Top 4% volume in TX
$4,499 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,559
Medicare services
Top 4% in TX for acute care nurse practitioner
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
351 | $33 | $166 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
191 | $2 | $16 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
175 | $8 | $97 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
148 | $75 | $368 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
143 | $57 | $250 |
| Nucleic acid test for organism quantification A laboratory test that uses nucleic acid detection to measure the amount of a specific organism present in a sample. |
81 | $41 | $222 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $35 | $150 |
| Simple change of bladder tube | 51 | $61 | $324 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
48 | $32 | $135 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
42 | $49 | $247 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
37 | $50 | $296 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
29 | $39 | $343 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
27 | $33 | $123 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
27 | $33 | $182 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
27 | $33 | $153 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
27 | $33 | $153 |
| Strep A nucleic acid test, quantification A laboratory test that uses nucleic acid detection to identify and measure the amount of Group A Streptococcus bacteria. |
27 | $40 | $146 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
27 | $33 | $123 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
21 | $50 | $348 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $88 | $565 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $79 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,499
Total received (2021-2024)
Avg $1,125/year across 4 years
Top 5% in TX for acute care nurse practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
207
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,557
2023
$1,343
2022
$1,555
2021
$43
Payments by company (2024)
Sumitomo Pharma America, Inc.
$431
PFIZER INC.
$202
Janssen Biotech, Inc.
$162
Endo USA, Inc.
$149
Bayer Healthcare Pharmaceuticals Inc.
$120
Verity Pharmaceuticals Inc.
$117
Boston Scientific Corporation
$66
ABBVIE INC.
$52
PROCEPT BioRobotics Corporation
$45
Olympus America Inc.
$44
Astellas Pharma US Inc
$44
Blue Earth Diagnostics Limited
$40
Avation Medical, Inc.
$32
Endo Pharmaceuticals Inc.
$21
PROGENICS PHARMACEUTICALS, INC.
$19
Antares Pharma, Inc.
$13
Top 3 companies account for 51.0% of 2024 payments
All-time payments by company (2021-2024) ›
Sumitomo Pharma America, Inc.
$742
Janssen Biotech, Inc.
$415
Boston Scientific Corporation
$309
Medtronic, Inc.
$300
PFIZER INC.
$271
Bayer Healthcare Pharmaceuticals Inc.
$240
Astellas Pharma US Inc
$160
Endo USA, Inc.
$149
Myovant Sciences Inc.
$142
ABBVIE INC.
$141
Endo Pharmaceuticals Inc.
$130
Accord Healthcare, Inc.
$126
UROVANT SCIENCES INC
$119
Verity Pharmaceuticals Inc.
$117
Teleflex LLC
$112
ConvaTec Inc.
$110
Bayer HealthCare Pharmaceuticals Inc.
$93
ACCORD HEALTHCARE, INC.
$92
PROCEPT BioRobotics Corporation
$89
Antares Pharma, Inc.
$70
Olympus America Inc.
$68
Progenics Pharmaceuticals, Inc.
$58
Myriad Genetic Laboratories, Inc.
$47
TOLMAR Pharmaceuticals, Inc.
$46
Blue Earth Diagnostics Limited
$40
Avation Medical, Inc.
$32
Supernus Pharmaceuticals, Inc.
$31
Lilly USA, LLC
$29
Photocure Inc
$25
Alnylam Pharmaceuticals Inc.
$22
Novartis Pharmaceuticals Corporation
$20
Coloplast Corp
$20
PROGENICS PHARMACEUTICALS, INC.
$19
Smith+Nephew, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
Travere Therapeutics, Inc.
$17
Axonics, Inc.
$17
Heron Therapeutics, Inc.
$17
Novo Nordisk Inc
$14
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AVYCAZ · Axonics · CAMCEVI · CYSVIEW · DALVANCE · EDEX · ELIGARD · ERLEADA · GEMTESA · GENTLECATH · GENTLECATH GLIDE · General - Erectile Dysfunction · General - Therapies · GreenLight XPS · INTERSTIM · LOCAMETZ · LUPRON DEPOT · LithoVue · Moses 550 DFL · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · OXLUMO · Ozempic · POSLUMA · PROLARIS · PYLARIFY · Rezum Generator · STRAVIX · Seglentis · SpeediCath · TRULICITY · Thiola · Trelstar · ULTOMIRIS · UROLIFT · UroLift System · Vivally · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · Zynrelef · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Acute care nurse practitioners in nearby ZIP areas
597
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
METHODIST DALLAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Brumsey is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Brumsey experienced with infectious disease dna/rna test?
Based on Medicare claims data, Brumsey performed 351 infectious disease dna/rna test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Brumsey receive payments from pharmaceutical companies?
Yes. Brumsey received a total of $4,499 from 40 companies across 207 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Brumsey's costs compare to other acute care nurse practitioners in Dallas?
Brumsey's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Brumsey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Acute Care Nurse Practitioners in Dallas
Browse acute care nurse practitioners in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Acute Care Nurse Practitioners in TX
Acute care nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Acute Care Nurse Practitioners in TX
Which TX acute care nurse practitioners receive the most from drug and device companies.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology